Magnotta Bipolar Disorder

A double-blind, randomized, sham-controlled clinical trial of cerebellar intermittent theta burst stimulation for bipolar disorder: Safety, tolerability, mood and cognitive effects

Tuesday, July 28, 2026
Nicholas T Trapp
Intermittent theta burst stimulation (iTBS) applied to the midline cerebellum has effects on mood and cognition in patients with neuropsychiatric disease. In bipolar disorder, depressive and cognitive symptoms are often inadequately treated with current therapeutic options. This randomized, double-blind, sham-controlled clinical trial evaluated the safety, tolerability, and efficacy of applying 10 sessions of iTBS, delivered twice daily, targeting cerebellar vermis (CBM-iTBS) in subjects with...

Impulsivity is associated with suicide attempt in mood disorders with complex moderation by diagnosis and subjective social status

Thursday, May 7, 2026
Pooya Hazegh
CONCLUSION: The relationship between impulsivity and suicide attempt is complex and moderated by diagnosis and SSS.

Brain Age in Bipolar Disorder: Impact of Model Selection and Clinical Factors

Friday, February 13, 2026
Natasha Topolski
CONCLUSIONS: Our findings support the presence of elevated brain age in BD and lithium's suggested neuroprotective profile and highlight the influence of the brain age model, MRI scanner, and other confounders on predictions.

Feasibility and accuracy of the ASERT digital questionnaire in mood tracking for a longitudinal research study on bipolar disorder

Monday, September 22, 2025
Isaac Lynch
CONCLUSIONS: The ASERT can be feasibly deployed to track mood and can help schedule follow-up assessments in BD longitudinal studies.